Predictive Risk Factors for Retinal Redetachment Following Uncomplicated Pars Plana Vitrectomy for Primary Rhegmatogenous Retinal Detachment
Overview
Affiliations
Purpose: To investigate clinical and surgical factors influencing the outcome after primary rhegmatogenous retinal detachment surgery.
Methods: A retrospective, single-centre, case-control study of 1017 eyes of 1017 consecutive patients with primary rhegmatogenous retinal detachment (RRD) who underwent pars plana vitrectomy (PPV), were included in the study. Analysed surgical factors were: combined procedure with phacoemulsification, type of retinopexy (cryocoagulation, endolaser, combined), type of tamponade (gas, silicone oil), and anatomical factors: primary proliferative vitreoretinopathy (PVR) and macular detachment at the time of surgery.
Results: Overall retinal re-detachment rate was 10.1%. The main reason for re-detachment was an insufficient retinopexy in 53.6%, followed by PVR (37.3%), and retinal detachment occurred at a different location caused by another break in 9.1%. No significant difference in the rate of re-detachment was found if a phacoemulsification with simultaneous IOL implantation was performed ( = 0.641). No significant difference between the various retinopexy techniques was found ( = 0.309). Risk factors re-detachment were primary PVR ( = 0.0003), silicone oil as initial tamponade ( = 0.0001) as well as macula off detachments ( = 0.034).
Conclusions: The present study showed no significant difference between the types of retinopexy and if additional phacoemulsification was performed or not. Factors associated with a higher risk for re-detachment were detached macula at surgery, primary PVR and primary oil-filling.
The Impact of Social Support on Postoperative Recovery in Retinal Detachment Surgery.
Castellano-Santana P, Cabrera-Lopez F, Martin-Alonso M, Flores-Jardo Y, Gonzalez-Martin J, Diaz-Ginory A Medicina (Kaunas). 2025; 61(2).
PMID: 40005391 PMC: 11857662. DOI: 10.3390/medicina61020273.
Gu R, Zhao J, Shi J, Zhu H, Jiang C Quant Imaging Med Surg. 2025; 15(2):1613-1620.
PMID: 39995731 PMC: 11847211. DOI: 10.21037/qims-24-1460.
Al-Dwairi R, Saleh O, Mohidat H, Al Beiruti S, Alshami A, El Taani L J Clin Med. 2025; 14(1.
PMID: 39797305 PMC: 11721734. DOI: 10.3390/jcm14010222.
Vaz S, Groheux D, van Nijnatten T, Antunovic L, Cardoso F, Mottaghy F Eur J Nucl Med Mol Imaging. 2024; 52(3):801-805.
PMID: 39706898 DOI: 10.1007/s00259-024-07042-9.
Yorston D, Donachie P, Laidlaw D, Steel D, Aylward G, Williamson T Eye (Lond). 2023; 37(8):1527-1537.
PMID: 37100934 PMC: 10219959. DOI: 10.1038/s41433-023-02388-0.